Drug intelligence / Profile preview

C027

Development stage
Preclinical
Lead developer
Nationwide Children's Hospital
Modality
Gene Silencing → Gene Therapies, Oncolytic Viruses → Oncolytic Therapeutics, Gene Editing → Gene Therapies, Gene Addition/Replacement → Gene Therapies
Administration
Intratumoral
01

Overview

**C027** is a preclinical, replication-competent oncolytic herpes simplex virus type 1 derived from C134 and engineered to express murine interleukin-27. Bicistronic murine IL-27 expression cassettes were inserted into the deleted γ134.5 loci under an MND promoter. C027 is intended for local treatment of malignant glioma, combining direct virus-mediated tumor-cell lysis with intratumoral IL-27 delivery to enhance antitumor T-cell activity, including cytotoxic CD8 T-cell function, T-helper 1 polarization, and durable antitumor immune memory. In syngeneic orthotopic murine glioma models, C027 improved survival; its benefit depended on IL-27 and T cells. ([jitc.bmj.com](https://jitc.bmj.com/content/13/7/e012227))

Other names
C134+IL27
02

Targets

IL-27R (Interleukin-27 receptor)

Beyond the preview

Go deeper on C027.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on C027.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call